Skip to main content
. 2016 Jan 6;70(5):548–553. doi: 10.1038/ejcn.2015.220

Table 2. Distribution of the prevalence of metabolic syndrome and its components according to the height-for-age Z-scores at 2 years of age from the 1982 Pelotas cohort study (1982–2004).

Clinical and biochemical data <−2
⩾−2
  N % N %
High fasting glucose (mg/dl) 92 19.7 479 16.1
Low HDL (mg/dl) 148 30.8* 749 24.7
High triglycerides (mg/dl) 60 12.5 536 17.6*
High mean arterial pressure (mm Hg) 142 26.4 821 24.1
High waist circumference (cm) 22 4.3 218 6.6*
Overweight (wt/ht2) 38 5.5 339 8.0
Obesity (wt/ht2) 7 1.0 46 1.1
 
Number of metabolic syndrome components presented
 0 168 35.0 1247 40.7
 1 200 41.7 1094 35.7
 2 84 17.5 506 16.5
 3 18 3.8 166 5.4
 4 8 1.6 46 1.5
 5 2 0.4 3 0.2
Metabolic syndrome 28 5.8 215 7.0

Abbreviation: HDL, high-density lipoprotein.

χ2-test. Asterisks indicate statistical significance. *P-value<0.05.